Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Journal of Gynecology Obstetrics and Human Reproduction|December 1, 2023
Impact of molecular genotyping on the diagnosis and treatment of human chorionic gonadotropin-producing tumorsM Peyle, M Massoud, S Patrier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancerA Gonçalves, J-Y Pierga, J-M Ferrero, et al.
The AAPS Journal|May 13, 2022
When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity PlatformGregor P Lotz, Karin Benstein, Karien Bloem, et al.
British Journal of Cancer|October 9, 1998
High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre studyC Chabannon, K Cornetta, J P Lotz, et al.
Bone Marrow Transplantation|May 29, 1998
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registryP Moreau, J Fleury, P Brice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2014
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II studyF Selle, S Wittnebel, P Biron, et al.
Nature Chemical Biology|November 1, 2011
Identifying polyglutamine protein species in situ that best predict neurodegenerationJason Miller, Montserrat Arrasate, Elizabeth Brooks, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCEJ Thariat, T Schouman, A Brouchet, et al.
Gynecologic Oncology|July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG networkF Derquin, A Floquet, A C Hardy-Bessard, et al.
Pageof 17